Rating History for Taysha Gene Therapies (TSHA) by Goldman Sachs
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 12/4/2025 | Salveen Richter | Upgrade | Buy (Early-Stage Biotech) |
11.00 (N/A) |
4.49 (4.57) |
1.78% | Details |
 |
|||||||
|
|||||||
|
|||||||
